Furthermore, some specific medications seem to worsen outcomes among patients with DM and heart failure and have therefore required caution when used in this population; however, other molecules, such as SGLT-2, have been demonstrated to have some CV benefits. The gene discussed is SLC5A2; the disease is diabetes mellitus.